- REPORT SUMMARY
- TABLE OF CONTENTS
-
Diagnostic Radioisotopes market report explains the definition, types, applications, major countries, and major players of the Diagnostic Radioisotopes market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Navidea
Eli Lilly
Curium Pharmaceuticals
Triad Isotopes
Bayer
SIEMENS
Dongcheng
Jubilant Pharma
Nordion
China Isotope & Radiation
Novartis
Lantheus
Bracco Imaging
GE Healthcare
By Type:
Tc-99m
F-18
Other
By End-User:
Oncology
Cardiology
Other
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Diagnostic Radioisotopes Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Diagnostic Radioisotopes Outlook to 2028- Original Forecasts
-
2.2 Diagnostic Radioisotopes Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Diagnostic Radioisotopes Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Diagnostic Radioisotopes Market- Recent Developments
-
6.1 Diagnostic Radioisotopes Market News and Developments
-
6.2 Diagnostic Radioisotopes Market Deals Landscape
7 Diagnostic Radioisotopes Raw Materials and Cost Structure Analysis
-
7.1 Diagnostic Radioisotopes Key Raw Materials
-
7.2 Diagnostic Radioisotopes Price Trend of Key Raw Materials
-
7.3 Diagnostic Radioisotopes Key Suppliers of Raw Materials
-
7.4 Diagnostic Radioisotopes Market Concentration Rate of Raw Materials
-
7.5 Diagnostic Radioisotopes Cost Structure Analysis
-
7.5.1 Diagnostic Radioisotopes Raw Materials Analysis
-
7.5.2 Diagnostic Radioisotopes Labor Cost Analysis
-
7.5.3 Diagnostic Radioisotopes Manufacturing Expenses Analysis
8 Global Diagnostic Radioisotopes Import and Export Analysis (Top 10 Countries)
-
8.1 Global Diagnostic Radioisotopes Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Diagnostic Radioisotopes Export by Region (Top 10 Countries) (2017-2028)
9 Global Diagnostic Radioisotopes Market Outlook by Types and Applications to 2022
-
9.1 Global Diagnostic Radioisotopes Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Tc-99m Consumption and Growth Rate (2017-2022)
-
9.1.2 Global F-18 Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Diagnostic Radioisotopes Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Oncology Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Cardiology Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Diagnostic Radioisotopes Market Analysis and Outlook till 2022
-
10.1 Global Diagnostic Radioisotopes Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Diagnostic Radioisotopes Consumption (2017-2022)
-
10.2.2 Canada Diagnostic Radioisotopes Consumption (2017-2022)
-
10.2.3 Mexico Diagnostic Radioisotopes Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Diagnostic Radioisotopes Consumption (2017-2022)
-
10.3.2 UK Diagnostic Radioisotopes Consumption (2017-2022)
-
10.3.3 Spain Diagnostic Radioisotopes Consumption (2017-2022)
-
10.3.4 Belgium Diagnostic Radioisotopes Consumption (2017-2022)
-
10.3.5 France Diagnostic Radioisotopes Consumption (2017-2022)
-
10.3.6 Italy Diagnostic Radioisotopes Consumption (2017-2022)
-
10.3.7 Denmark Diagnostic Radioisotopes Consumption (2017-2022)
-
10.3.8 Finland Diagnostic Radioisotopes Consumption (2017-2022)
-
10.3.9 Norway Diagnostic Radioisotopes Consumption (2017-2022)
-
10.3.10 Sweden Diagnostic Radioisotopes Consumption (2017-2022)
-
10.3.11 Poland Diagnostic Radioisotopes Consumption (2017-2022)
-
10.3.12 Russia Diagnostic Radioisotopes Consumption (2017-2022)
-
10.3.13 Turkey Diagnostic Radioisotopes Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Diagnostic Radioisotopes Consumption (2017-2022)
-
10.4.2 Japan Diagnostic Radioisotopes Consumption (2017-2022)
-
10.4.3 India Diagnostic Radioisotopes Consumption (2017-2022)
-
10.4.4 South Korea Diagnostic Radioisotopes Consumption (2017-2022)
-
10.4.5 Pakistan Diagnostic Radioisotopes Consumption (2017-2022)
-
10.4.6 Bangladesh Diagnostic Radioisotopes Consumption (2017-2022)
-
10.4.7 Indonesia Diagnostic Radioisotopes Consumption (2017-2022)
-
10.4.8 Thailand Diagnostic Radioisotopes Consumption (2017-2022)
-
10.4.9 Singapore Diagnostic Radioisotopes Consumption (2017-2022)
-
10.4.10 Malaysia Diagnostic Radioisotopes Consumption (2017-2022)
-
10.4.11 Philippines Diagnostic Radioisotopes Consumption (2017-2022)
-
10.4.12 Vietnam Diagnostic Radioisotopes Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Diagnostic Radioisotopes Consumption (2017-2022)
-
10.5.2 Colombia Diagnostic Radioisotopes Consumption (2017-2022)
-
10.5.3 Chile Diagnostic Radioisotopes Consumption (2017-2022)
-
10.5.4 Argentina Diagnostic Radioisotopes Consumption (2017-2022)
-
10.5.5 Venezuela Diagnostic Radioisotopes Consumption (2017-2022)
-
10.5.6 Peru Diagnostic Radioisotopes Consumption (2017-2022)
-
10.5.7 Puerto Rico Diagnostic Radioisotopes Consumption (2017-2022)
-
10.5.8 Ecuador Diagnostic Radioisotopes Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Diagnostic Radioisotopes Consumption (2017-2022)
-
10.6.2 Kuwait Diagnostic Radioisotopes Consumption (2017-2022)
-
10.6.3 Oman Diagnostic Radioisotopes Consumption (2017-2022)
-
10.6.4 Qatar Diagnostic Radioisotopes Consumption (2017-2022)
-
10.6.5 Saudi Arabia Diagnostic Radioisotopes Consumption (2017-2022)
-
10.6.6 United Arab Emirates Diagnostic Radioisotopes Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Diagnostic Radioisotopes Consumption (2017-2022)
-
10.7.2 South Africa Diagnostic Radioisotopes Consumption (2017-2022)
-
10.7.3 Egypt Diagnostic Radioisotopes Consumption (2017-2022)
-
10.7.4 Algeria Diagnostic Radioisotopes Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Diagnostic Radioisotopes Consumption (2017-2022)
-
10.8.2 New Zealand Diagnostic Radioisotopes Consumption (2017-2022)
11 Global Diagnostic Radioisotopes Competitive Analysis
-
11.1 Navidea
-
11.1.1 Navidea Company Details
-
11.1.2 Navidea Diagnostic Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Navidea Diagnostic Radioisotopes Main Business and Markets Served
-
11.1.4 Navidea Diagnostic Radioisotopes Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Eli Lilly
-
11.2.1 Eli Lilly Company Details
-
11.2.2 Eli Lilly Diagnostic Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Eli Lilly Diagnostic Radioisotopes Main Business and Markets Served
-
11.2.4 Eli Lilly Diagnostic Radioisotopes Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Curium Pharmaceuticals
-
11.3.1 Curium Pharmaceuticals Company Details
-
11.3.2 Curium Pharmaceuticals Diagnostic Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Curium Pharmaceuticals Diagnostic Radioisotopes Main Business and Markets Served
-
11.3.4 Curium Pharmaceuticals Diagnostic Radioisotopes Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Triad Isotopes
-
11.4.1 Triad Isotopes Company Details
-
11.4.2 Triad Isotopes Diagnostic Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Triad Isotopes Diagnostic Radioisotopes Main Business and Markets Served
-
11.4.4 Triad Isotopes Diagnostic Radioisotopes Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Bayer
-
11.5.1 Bayer Company Details
-
11.5.2 Bayer Diagnostic Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Bayer Diagnostic Radioisotopes Main Business and Markets Served
-
11.5.4 Bayer Diagnostic Radioisotopes Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 SIEMENS
-
11.6.1 SIEMENS Company Details
-
11.6.2 SIEMENS Diagnostic Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 SIEMENS Diagnostic Radioisotopes Main Business and Markets Served
-
11.6.4 SIEMENS Diagnostic Radioisotopes Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Dongcheng
-
11.7.1 Dongcheng Company Details
-
11.7.2 Dongcheng Diagnostic Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Dongcheng Diagnostic Radioisotopes Main Business and Markets Served
-
11.7.4 Dongcheng Diagnostic Radioisotopes Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Jubilant Pharma
-
11.8.1 Jubilant Pharma Company Details
-
11.8.2 Jubilant Pharma Diagnostic Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Jubilant Pharma Diagnostic Radioisotopes Main Business and Markets Served
-
11.8.4 Jubilant Pharma Diagnostic Radioisotopes Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Nordion
-
11.9.1 Nordion Company Details
-
11.9.2 Nordion Diagnostic Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Nordion Diagnostic Radioisotopes Main Business and Markets Served
-
11.9.4 Nordion Diagnostic Radioisotopes Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 China Isotope & Radiation
-
11.10.1 China Isotope & Radiation Company Details
-
11.10.2 China Isotope & Radiation Diagnostic Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 China Isotope & Radiation Diagnostic Radioisotopes Main Business and Markets Served
-
11.10.4 China Isotope & Radiation Diagnostic Radioisotopes Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Novartis
-
11.11.1 Novartis Company Details
-
11.11.2 Novartis Diagnostic Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Novartis Diagnostic Radioisotopes Main Business and Markets Served
-
11.11.4 Novartis Diagnostic Radioisotopes Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Lantheus
-
11.12.1 Lantheus Company Details
-
11.12.2 Lantheus Diagnostic Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Lantheus Diagnostic Radioisotopes Main Business and Markets Served
-
11.12.4 Lantheus Diagnostic Radioisotopes Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Bracco Imaging
-
11.13.1 Bracco Imaging Company Details
-
11.13.2 Bracco Imaging Diagnostic Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Bracco Imaging Diagnostic Radioisotopes Main Business and Markets Served
-
11.13.4 Bracco Imaging Diagnostic Radioisotopes Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 GE Healthcare
-
11.14.1 GE Healthcare Company Details
-
11.14.2 GE Healthcare Diagnostic Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 GE Healthcare Diagnostic Radioisotopes Main Business and Markets Served
-
11.14.4 GE Healthcare Diagnostic Radioisotopes Product Portfolio
-
11.14.5 Recent Research and Development Strategies
12 Global Diagnostic Radioisotopes Market Outlook by Types and Applications to 2028
-
12.1 Global Diagnostic Radioisotopes Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Tc-99m Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global F-18 Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Diagnostic Radioisotopes Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Cardiology Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Diagnostic Radioisotopes Market Analysis and Outlook to 2028
-
13.1 Global Diagnostic Radioisotopes Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Diagnostic Radioisotopes Consumption Forecast (2022-2028)
-
13.2.2 Canada Diagnostic Radioisotopes Consumption Forecast (2022-2028)
-
13.2.3 Mexico Diagnostic Radioisotopes Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Diagnostic Radioisotopes Consumption Forecast (2022-2028)
-
13.3.2 UK Diagnostic Radioisotopes Consumption Forecast (2022-2028)
-
13.3.3 Spain Diagnostic Radioisotopes Consumption Forecast (2022-2028)
-
13.3.4 Belgium Diagnostic Radioisotopes Consumption Forecast (2022-2028)
-
13.3.5 France Diagnostic Radioisotopes Consumption Forecast (2022-2028)
-
13.3.6 Italy Diagnostic Radioisotopes Consumption Forecast (2022-2028)
-
13.3.7 Denmark Diagnostic Radioisotopes Consumption Forecast (2022-2028)
-
13.3.8 Finland Diagnostic Radioisotopes Consumption Forecast (2022-2028)
-
13.3.9 Norway Diagnostic Radioisotopes Consumption Forecast (2022-2028)
-
13.3.10 Sweden Diagnostic Radioisotopes Consumption Forecast (2022-2028)
-
13.3.11 Poland Diagnostic Radioisotopes Consumption Forecast (2022-2028)
-
13.3.12 Russia Diagnostic Radioisotopes Consumption Forecast (2022-2028)
-
13.3.13 Turkey Diagnostic Radioisotopes Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Diagnostic Radioisotopes Consumption Forecast (2022-2028)
-
13.4.2 Japan Diagnostic Radioisotopes Consumption Forecast (2022-2028)
-
13.4.3 India Diagnostic Radioisotopes Consumption Forecast (2022-2028)
-
13.4.4 South Korea Diagnostic Radioisotopes Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Diagnostic Radioisotopes Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Diagnostic Radioisotopes Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Diagnostic Radioisotopes Consumption Forecast (2022-2028)
-
13.4.8 Thailand Diagnostic Radioisotopes Consumption Forecast (2022-2028)
-
13.4.9 Singapore Diagnostic Radioisotopes Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Diagnostic Radioisotopes Consumption Forecast (2022-2028)
-
13.4.11 Philippines Diagnostic Radioisotopes Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Diagnostic Radioisotopes Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Diagnostic Radioisotopes Consumption Forecast (2022-2028)
-
13.5.2 Colombia Diagnostic Radioisotopes Consumption Forecast (2022-2028)
-
13.5.3 Chile Diagnostic Radioisotopes Consumption Forecast (2022-2028)
-
13.5.4 Argentina Diagnostic Radioisotopes Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Diagnostic Radioisotopes Consumption Forecast (2022-2028)
-
13.5.6 Peru Diagnostic Radioisotopes Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Diagnostic Radioisotopes Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Diagnostic Radioisotopes Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Diagnostic Radioisotopes Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Diagnostic Radioisotopes Consumption Forecast (2022-2028)
-
13.6.3 Oman Diagnostic Radioisotopes Consumption Forecast (2022-2028)
-
13.6.4 Qatar Diagnostic Radioisotopes Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Diagnostic Radioisotopes Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Diagnostic Radioisotopes Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Diagnostic Radioisotopes Consumption Forecast (2022-2028)
-
13.7.2 South Africa Diagnostic Radioisotopes Consumption Forecast (2022-2028)
-
13.7.3 Egypt Diagnostic Radioisotopes Consumption Forecast (2022-2028)
-
13.7.4 Algeria Diagnostic Radioisotopes Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Diagnostic Radioisotopes Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Diagnostic Radioisotopes Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Diagnostic Radioisotopes
-
Figure of Diagnostic Radioisotopes Picture
-
Table Global Diagnostic Radioisotopes Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Diagnostic Radioisotopes Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Tc-99m Consumption and Growth Rate (2017-2022)
-
Figure Global F-18 Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Oncology Consumption and Growth Rate (2017-2022)
-
Figure Global Cardiology Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Diagnostic Radioisotopes Consumption by Country (2017-2022)
-
Table North America Diagnostic Radioisotopes Consumption by Country (2017-2022)
-
Figure United States Diagnostic Radioisotopes Consumption and Growth Rate (2017-2022)
-
Figure Canada Diagnostic Radioisotopes Consumption and Growth Rate (2017-2022)
-
Figure Mexico Diagnostic Radioisotopes Consumption and Growth Rate (2017-2022)
-
Table Europe Diagnostic Radioisotopes Consumption by Country (2017-2022)
-
Figure Germany Diagnostic Radioisotopes Consumption and Growth Rate (2017-2022)
-
Figure UK Diagnostic Radioisotopes Consumption and Growth Rate (2017-2022)
-
Figure Spain Diagnostic Radioisotopes Consumption and Growth Rate (2017-2022)
-
Figure Belgium Diagnostic Radioisotopes Consumption and Growth Rate (2017-2022)
-
Figure France Diagnostic Radioisotopes Consumption and Growth Rate (2017-2022)
-
Figure Italy Diagnostic Radioisotopes Consumption and Growth Rate (2017-2022)
-
Figure Denmark Diagnostic Radioisotopes Consumption and Growth Rate (2017-2022)
-
Figure Finland Diagnostic Radioisotopes Consumption and Growth Rate (2017-2022)
-
Figure Norway Diagnostic Radioisotopes Consumption and Growth Rate (2017-2022)
-
Figure Sweden Diagnostic Radioisotopes Consumption and Growth Rate (2017-2022)
-
Figure Poland Diagnostic Radioisotopes Consumption and Growth Rate (2017-2022)
-
Figure Russia Diagnostic Radioisotopes Consumption and Growth Rate (2017-2022)
-
Figure Turkey Diagnostic Radioisotopes Consumption and Growth Rate (2017-2022)
-
Table APAC Diagnostic Radioisotopes Consumption by Country (2017-2022)
-
Figure China Diagnostic Radioisotopes Consumption and Growth Rate (2017-2022)
-
Figure Japan Diagnostic Radioisotopes Consumption and Growth Rate (2017-2022)
-
Figure India Diagnostic Radioisotopes Consumption and Growth Rate (2017-2022)
-
Figure South Korea Diagnostic Radioisotopes Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Diagnostic Radioisotopes Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Diagnostic Radioisotopes Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Diagnostic Radioisotopes Consumption and Growth Rate (2017-2022)
-
Figure Thailand Diagnostic Radioisotopes Consumption and Growth Rate (2017-2022)
-
Figure Singapore Diagnostic Radioisotopes Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Diagnostic Radioisotopes Consumption and Growth Rate (2017-2022)
-
Figure Philippines Diagnostic Radioisotopes Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Diagnostic Radioisotopes Consumption and Growth Rate (2017-2022)
-
Table South America Diagnostic Radioisotopes Consumption by Country (2017-2022)
-
Figure Brazil Diagnostic Radioisotopes Consumption and Growth Rate (2017-2022)
-
Figure Colombia Diagnostic Radioisotopes Consumption and Growth Rate (2017-2022)
-
Figure Chile Diagnostic Radioisotopes Consumption and Growth Rate (2017-2022)
-
Figure Argentina Diagnostic Radioisotopes Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Diagnostic Radioisotopes Consumption and Growth Rate (2017-2022)
-
Figure Peru Diagnostic Radioisotopes Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Diagnostic Radioisotopes Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Diagnostic Radioisotopes Consumption and Growth Rate (2017-2022)
-
Table GCC Diagnostic Radioisotopes Consumption by Country (2017-2022)
-
Figure Bahrain Diagnostic Radioisotopes Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Diagnostic Radioisotopes Consumption and Growth Rate (2017-2022)
-
Figure Oman Diagnostic Radioisotopes Consumption and Growth Rate (2017-2022)
-
Figure Qatar Diagnostic Radioisotopes Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Diagnostic Radioisotopes Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Diagnostic Radioisotopes Consumption and Growth Rate (2017-2022)
-
Table Africa Diagnostic Radioisotopes Consumption by Country (2017-2022)
-
Figure Nigeria Diagnostic Radioisotopes Consumption and Growth Rate (2017-2022)
-
Figure South Africa Diagnostic Radioisotopes Consumption and Growth Rate (2017-2022)
-
Figure Egypt Diagnostic Radioisotopes Consumption and Growth Rate (2017-2022)
-
Figure Algeria Diagnostic Radioisotopes Consumption and Growth Rate (2017-2022)
-
Table Oceania Diagnostic Radioisotopes Consumption by Country (2017-2022)
-
Figure Australia Diagnostic Radioisotopes Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Diagnostic Radioisotopes Consumption and Growth Rate (2017-2022)
-
Table Navidea Company Details
-
Table Navidea Diagnostic Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)
-
Table Navidea Diagnostic Radioisotopes Main Business and Markets Served
-
Table Navidea Diagnostic Radioisotopes Product Portfolio
-
Table Eli Lilly Company Details
-
Table Eli Lilly Diagnostic Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Diagnostic Radioisotopes Main Business and Markets Served
-
Table Eli Lilly Diagnostic Radioisotopes Product Portfolio
-
Table Curium Pharmaceuticals Company Details
-
Table Curium Pharmaceuticals Diagnostic Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)
-
Table Curium Pharmaceuticals Diagnostic Radioisotopes Main Business and Markets Served
-
Table Curium Pharmaceuticals Diagnostic Radioisotopes Product Portfolio
-
Table Triad Isotopes Company Details
-
Table Triad Isotopes Diagnostic Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)
-
Table Triad Isotopes Diagnostic Radioisotopes Main Business and Markets Served
-
Table Triad Isotopes Diagnostic Radioisotopes Product Portfolio
-
Table Bayer Company Details
-
Table Bayer Diagnostic Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Diagnostic Radioisotopes Main Business and Markets Served
-
Table Bayer Diagnostic Radioisotopes Product Portfolio
-
Table SIEMENS Company Details
-
Table SIEMENS Diagnostic Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)
-
Table SIEMENS Diagnostic Radioisotopes Main Business and Markets Served
-
Table SIEMENS Diagnostic Radioisotopes Product Portfolio
-
Table Dongcheng Company Details
-
Table Dongcheng Diagnostic Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dongcheng Diagnostic Radioisotopes Main Business and Markets Served
-
Table Dongcheng Diagnostic Radioisotopes Product Portfolio
-
Table Jubilant Pharma Company Details
-
Table Jubilant Pharma Diagnostic Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)
-
Table Jubilant Pharma Diagnostic Radioisotopes Main Business and Markets Served
-
Table Jubilant Pharma Diagnostic Radioisotopes Product Portfolio
-
Table Nordion Company Details
-
Table Nordion Diagnostic Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)
-
Table Nordion Diagnostic Radioisotopes Main Business and Markets Served
-
Table Nordion Diagnostic Radioisotopes Product Portfolio
-
Table China Isotope & Radiation Company Details
-
Table China Isotope & Radiation Diagnostic Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)
-
Table China Isotope & Radiation Diagnostic Radioisotopes Main Business and Markets Served
-
Table China Isotope & Radiation Diagnostic Radioisotopes Product Portfolio
-
Table Novartis Company Details
-
Table Novartis Diagnostic Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Diagnostic Radioisotopes Main Business and Markets Served
-
Table Novartis Diagnostic Radioisotopes Product Portfolio
-
Table Lantheus Company Details
-
Table Lantheus Diagnostic Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lantheus Diagnostic Radioisotopes Main Business and Markets Served
-
Table Lantheus Diagnostic Radioisotopes Product Portfolio
-
Table Bracco Imaging Company Details
-
Table Bracco Imaging Diagnostic Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bracco Imaging Diagnostic Radioisotopes Main Business and Markets Served
-
Table Bracco Imaging Diagnostic Radioisotopes Product Portfolio
-
Table GE Healthcare Company Details
-
Table GE Healthcare Diagnostic Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)
-
Table GE Healthcare Diagnostic Radioisotopes Main Business and Markets Served
-
Table GE Healthcare Diagnostic Radioisotopes Product Portfolio
-
Figure Global Tc-99m Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global F-18 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cardiology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diagnostic Radioisotopes Consumption Forecast by Country (2022-2028)
-
Table North America Diagnostic Radioisotopes Consumption Forecast by Country (2022-2028)
-
Figure United States Diagnostic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Diagnostic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Diagnostic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Diagnostic Radioisotopes Consumption Forecast by Country (2022-2028)
-
Figure Germany Diagnostic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Diagnostic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Diagnostic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Diagnostic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Diagnostic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Diagnostic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Diagnostic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Diagnostic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Diagnostic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Diagnostic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Diagnostic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Diagnostic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Diagnostic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Diagnostic Radioisotopes Consumption Forecast by Country (2022-2028)
-
Figure China Diagnostic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Diagnostic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Diagnostic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Diagnostic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Diagnostic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Diagnostic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Diagnostic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Diagnostic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Diagnostic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Diagnostic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Diagnostic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Diagnostic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Diagnostic Radioisotopes Consumption Forecast by Country (2022-2028)
-
Figure Brazil Diagnostic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Diagnostic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Diagnostic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Diagnostic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Diagnostic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Diagnostic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Diagnostic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Diagnostic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Diagnostic Radioisotopes Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Diagnostic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Diagnostic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Diagnostic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Diagnostic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Diagnostic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Diagnostic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Diagnostic Radioisotopes Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Diagnostic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Diagnostic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Diagnostic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Diagnostic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Diagnostic Radioisotopes Consumption Forecast by Country (2022-2028)
-
Figure Australia Diagnostic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Diagnostic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)
-